Breaking News, Collaborations & Alliances

Resilience Enters Collaboration with Takeda

Establishes multi-product development and manufacturing collaboration with Takeda’s plasma-derived therapies business unit.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

National Resilience, Inc., a technology-focused manufacturing company dedicated to broadening access to complex medicines, today announced a manufacturing services agreement with Takeda’s plasma-derived therapies business unit. As part of the agreement, Resilience will focus on supporting the development and manufacture of multiple products in Takeda’s plasma-derived medicines portfolio out of its facility in Mississauga, Ontario. “I’m proud to establish this relationship with Takeda, a co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters